{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-024570","form_type":"8-K","ticker":"MLAB","cik":"0000724004","company_name":"MESA LABORATORIES INC /CO/","filed_at":"2024-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.713421+00:00","generated_at":"2026-05-31T13:17:04.345033+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Mesa Labs Q1 revenue $58.2M (+14.9%), EPS $0.62; operating income up 940%","bullets":["Revenue $58.2M (+14.9% YoY); net income $3.4M (+717%); diluted EPS $0.62.","Non-GAAP core organic revenue growth 3.0%; AOI excl. unusual items $15.3M (+47%).","Divisions: BPD core organic growth 23.5%; CG declined 14.3% (China/US headwinds).","Repaid $9.4M debt; net leverage ratio reduced to 3.41 (target <3.0x).","GKE acquisition contributing above expectations; non-cash inventory step-up charges to end by 2Q25."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-024570","json":"https://secwatch.observer/filing/0001437749-24-024570.json","markdown":"https://secwatch.observer/filing/0001437749-24-024570.md","text":"https://secwatch.observer/filing/0001437749-24-024570.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/724004/000143774924024570/0001437749-24-024570-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/724004/000143774924024570/mlab20240802_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:17:04.345033+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}